Literature DB >> 3839840

Long-term administration of massive doses of Sn-protoporphyrin in anemic mutant mice (sphha/sphha).

S Sassa, G S Drummond, S E Bernstein, A Kappas.   

Abstract

The effects of long-term administration of very large doses of Sn-protoporphyrin on hematological indices, histological changes, plasma bilirubin levels, tissue heme oxygenase activity, and activities of heme biosynthetic enzymes, were examined in genetically anemic mutant mice with hemolytic anemia (sphha/sphha). Long-term weekly treatment with Sn-protoporphyrin (100 mumol/kg body weight for 32 wk) did not alter hematological indices, histological findings, or enzyme activities related to heme biosynthesis, even though it resulted in sustained decreases in microsomal heme oxygenase activity in the liver, kidney, and spleen, and a prolonged decrease in plasma bilirubin concentration. Inhibition of heme oxygenase did not alter the level of cytochrome P-450 in the liver and the kidney. The results indicate that long-term treatment with massive doses of Sn-protoporphyrin suppresses bilirubin formation but does not produce significant histopathological changes or appreciably interfere with heme synthesis, in this strain of genetically anemic mice. These findings provide further support for the idea that suppression of heme degradation to bile pigment by the inhibition of heme oxygenase may prove useful to the prevention of severe hyperbilirubinemia in humans.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3839840      PMCID: PMC2187816          DOI: 10.1084/jem.162.3.864

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  20 in total

1.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE.

Authors:  T OMURA; R SATO
Journal:  J Biol Chem       Date:  1964-07       Impact factor: 5.157

2.  Heme biosynthesis and drug metabolism in mice with hereditary hemolytic anemia. Heme oxygenase induction as an adaptive response for maintaining cytochrome P-450 in chronic hemolysis.

Authors:  S Sassa; A Kappas; S E Bernstein; A P Alvares
Journal:  J Biol Chem       Date:  1979-02-10       Impact factor: 5.157

3.  Chemoprevention of neonatal jaundice: potency of tin-protoporphyrin in an animal model.

Authors:  G S Drummond; A Kappas
Journal:  Science       Date:  1982-09-24       Impact factor: 47.728

4.  [Fluorimetric assay of bilirubin].

Authors:  M Roth
Journal:  Clin Chim Acta       Date:  1967-09       Impact factor: 3.786

Review 5.  Inherited hemolytic disease in mice: a review and update.

Authors:  S E Bernstein
Journal:  Lab Anim Sci       Date:  1980-04

6.  Tin-protoporphyrin suppression of hyperbilirubinemia in mutant mice with severe hemolytic anemia.

Authors:  S Sassa; G S Drummond; S E Bernstein; A Kappas
Journal:  Blood       Date:  1983-05       Impact factor: 22.113

7.  Purification and properties of bovine spleen heme oxygenase. Amino acid composition and sites of action of inhibitors of heme oxidation.

Authors:  T Yoshinaga; S Sassa; A Kappas
Journal:  J Biol Chem       Date:  1982-07-10       Impact factor: 5.157

8.  Prevention of neonatal hyperbilirubinemia by tin protoporphyrin IX, a potent competitive inhibitor of heme oxidation.

Authors:  G S Drummond; A Kappas
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

9.  Studies on the pathogenesis of pigment gallstones in hemolytic anemia: description and characteristics of a mouse model.

Authors:  B W Trotman; S E Bernstein; K E Bove; G D Wirt
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

10.  Levels of delta-aminolevulinate dehydratase, uroporphyrinogen-I synthase, and protoporphyrin IX in erythrocytes from anemic mutant mice.

Authors:  S Sassa; S E Bernstein
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

View more
  4 in total

1.  Sn-protoporphyrin inhibition of fetal and neonatal brain heme oxygenase. Transplacental passage of the metalloporphyrin and prenatal suppression of hyperbilirubinemia in the newborn animal.

Authors:  G S Drummond; A Kappas
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

Review 2.  Control of heme metabolism with synthetic metalloporphyrins.

Authors:  A Kappas; G S Drummond
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

3.  Clinicopathologic features of young and old sphha/sphha mice. Mutants with congenital hemolytic anemia.

Authors:  L Maggio-Price; R Russell; N S Wolf; C E Alpers; D Engel
Journal:  Am J Pathol       Date:  1988-09       Impact factor: 4.307

4.  Sn-protoporphyrin suppresses chemically induced experimental hepatic porphyria. Potential clinical implications.

Authors:  R A Galbraith; G S Drummond; A Kappas
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.